Authors


Christopher Danes, PhD

Latest:

ASCO 2025: Using Discrete Choice Data to Support Personalized Pharmacy Counseling in ALK+ NSCLC

Christopher Danes, PhD, discusses how discrete choice experiment data reveal key differences in patient and caregiver treatment preferences for ALK-positive (ALK+) non–small cell lung cancer (NSCLC) and how pharmacists can use these insights to guide shared decision-making, optimize supportive care, and personalize adherence strategies.


Asad Ghani

Latest:

Deprescribing Helps Optimize Medication Use

Frequent reassessments of therapy regimens address polypharmacy, particularly for older patients.


Neo Su and Ben Shirley

Latest:

PQA and CPF Lead National Initiative to Prioritize Pharmacy Measure Concepts

Concepts could be used in payer-pharmacy value-based arrangements.


Shaji Kumar, MD

Latest:

Dual-Antigen Targeting in Myeloma: Improved Responses in Extramedullary Disease

Shaji Kumar, MD, shares data and insights from the phase 2 RedirecTT-1 study.


Lindsey Mulrooney

Latest:

Study: Receipt of Medications Relatively Stable During COVID-19 Pandemic

Research shows receipt of medications for chronic conditions was relatively stable in the first 2 years of the pandemic from 2020 to 2021 across racial and ethnic groups.


William Creed Carleton, PharmD Candidate

Latest:

ADHD Awareness Month and the Pharmacist’s Role

ADHD Awareness Months brings attention to a common, but still somewhat misunderstood condition that pharmacists encounter on a near daily basis.


Rachel Winters, PharmD

Latest:

An Appeal to Mitigate Health Disparities in Asthma

Pharmacists can help address the significant asthma health disparities among racial, ethnic, and socioeconomic groups to help improve outcomes.


Vidhi Patel, PharmD Candidate

Latest:

An Overlook of Cagrilintinide and Semaglutide as it Progresses Through Phase 3 Trials

CagriSema is a subcutaneous injectable combination of cagrilintide and semaglutide that is currently in phase 3 trials.



Matthew Ezzo, EdD, MBA

Latest:

Study Reveals Virtual Reality Effectively Educates Pharmacists on Continuous Glucose Monitors

Community pharmacists are uniquely positioned to assist with diabetes management using CGM devices.


Omolara Falade, PharmD Candidate

Latest:

Managing Blood Glucose Levels for Expectant Mothers With Diabetes

CGM enhances diabetes management in pregnancy, improving outcomes.


Fiona Lee, PharmD Candidate

Latest:

Lodoco: A New Indication for an Old Drug

Historically, colchicine has been used primarily in the management of gout; however, in 2023, the FDA approved Lodoco, a newly marketed colchicine product, for the management of cardiovascular disease.


Madison Holmes, PharmD, BPCS; Amy Renaud, PharmD; Chenita Carter, PharmD, MS; Ndia Hall, PharmD Candidate; Unique Allen, PharmD Candidate; Sebastian Alvarez, PharmD Candidate; Sheryl Smith, PharmD Candidate

Latest:

Summertime Medication Sun Safety Tips

With the vast number of drugs that can induce photosensitivity, patients taking any of these medications should receive safety counseling, especially during the summer months.


Connor M. Bunch, MD

Latest:

Impact of Pharmacist-Led Initiatives on Health Care–Associated Clostridioides difficile Rates

Antimicrobial stewardship efforts focusing on accurate penicillin allergy histories, β-lactam cross-reactivity education, and guideline-driven narrow-spectrum prescribing may help sustainably decrease health care–associated Clostridioides difficile infection rates.


Elham Mowlavi, PharmD Candidate

Latest:

Novel Combination Targeting BCR::ABL1 in Ph+ ALL With TKIs, STAMP-Inhibitor Is Very Well Tolerated

Pharmacists will play a significant role in TKI adherence rates among patients.


Troy J. Smith, PharmD, BSChE

Latest:

Educational Opportunities Exist for the Pharmaceutical Care of Animals

Interested individuals may gain certification or continuing-education credits, many of which are available through the American College of Veterinary Pharmacists.


Kristin Allen, PharmD

Latest:

Five Unexpected New Uses for GLP-1 Receptor Agonists

Data have shown the potential for the therapy to treat several new conditions.


Nan Li, PharmD

Latest:

The July Spike in Ordering Errors: A Call for Proactive Pharmacy Involvement

Pharmacists play a critical role in preventing medication ordering errors during residency onboarding through proactive training, system safeguards, and interdisciplinary collaboration.



Melissa Cloyd, PharmD, BCPS, BCPP, BCGP, DPLA

Latest:

The Patient Journey: Navigating TD From Young Adults to Older Ones

Panelists discuss how the patient journey with tardive dyskinesia involves evolving awareness and management of symptoms alongside underlying psychiatric conditions, highlighting the distinct needs of younger vs older patients and the essential role of pharmacists in supporting individualized, function-focused care throughout the lifespan.


Ami Patel, PharmD, BCPS

Latest:

Understand the Differences in Carbidopa/Levodopa Formulations for Parkinson Disease

Understanding differences in the various levodopa formulations and assisting with medication therapy management is a crucial role for pharmacists.


Rezarta Lako, PharmD, BCPS

Latest:

Emerging Role of BRAF Inhibitors in Relapsed/Refractory Hairy Cell Leukemia Treatment

BRAF V600E inhibitors show improved outcomes in relapsed/refractory hairy cell leukemia.


Sandi Perry, PharmD Candidate

Latest:

The Pharmacist’s Role in Bleeding Disorders

Pharmacists are an important part of the care team for patients with bleeding disorders, providing services such as medication counseling and reconciliation.


Jim Lichauer, PharmD, BCPS, FASHP

Latest:

The Promise of Biosimilars Is Within Reach for Health Systems

A collaborative exercise with 16 health care organizations nets millions in savings.


Olivia Riggi, PharmD Candidate

Latest:

Staying in the Know: Pharmacists, Drug Shortages, and What Lies Ahead

Pharmacists should be aware of current discussions, attempted fixes, and expected length of drug shortages.


Ming Zhu Lee, PharmD Candidate

Latest:

Lodoco: A New Indication for an Old Drug

Historically, colchicine has been used primarily in the management of gout; however, in 2023, the FDA approved Lodoco, a newly marketed colchicine product, for the management of cardiovascular disease.


Mindy Chen, BS, PharmD Candidate; and Shane P. Desselle, RPh, PhD, FAPhA

Latest:

Tip of the Week: The Time is Now to Provide Telehealth, Telepharmacy Services

The Covid-19 pandemic has elevated telehealth as a viable alternative to face-to-face interactions under certain circumstances, the list of which is expanding as technology expands and clinicians become more accustomed to and adept in its use.


Valerie Wasem, BS

Latest:

Postpandemic Future Is Bright for Technicians

Tapping techs as immunizers opens up greater visibility and new source of health care labor.


Brian Walker, RPh

Latest:

New Therapeutic Agents and Final Thoughts on DED

A panel of experts comment on new therapeutic agents being developed and discuss their final thoughts on dry eye disease.